Fusion Protein of RBP and Albumin Domain III Reduces Lung Fibrosis by Inactivating Lung Stellate Cells

Activated stellate cells play a role in fibrosis development in the liver, pancreas, and kidneys. The fusion protein R-III, which consists of retinol-binding protein and albumin domain III, has been demonstrated to attenuate liver and renal fibrosis by suppressing stellate cell activation. In this study, we investigated the efficacy of R-III against bleomycin-induced lung fibrosis in mice. R-III reduced lung fibrosis and primarily localized in autofluorescent cells in the lung tissue. Furthermore, we isolated lung stellate cells (LSCs) from rat lungs using the isolation protocol employed for hepatic stellate cells (HSCs). LSCs shared many characteristics with HSCs, including the presence of vitamin A-containing lipid droplets and the expression of alpha-smooth muscle actin and collagen type I, markers for activated HSCs/myofibroblasts. LSCs spontaneously transdifferentiated into myofibroblasts in in vitro culture, which was inhibited by R-III. These findings suggest that R-III may reduce lung fibrosis by inactivating LSCs and could be a promising treatment for extrahepatic fibrosis.

[1]  K. McCommis,et al.  Hepatic stellate cells in physiology and pathology , 2022, The Journal of physiology.

[2]  D. Cha,et al.  Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis , 2020, Biomedicines.

[3]  E. Crouchet,et al.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives , 2020, Cells.

[4]  B. Bartosch,et al.  Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis , 2019, Cells.

[5]  F. Tacke,et al.  Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. , 2019, Molecular aspects of medicine.

[6]  L. Richeldi,et al.  Idiopathic pulmonary fibrosis: pathogenesis and management , 2018, Respiratory Research.

[7]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[8]  Mark G. Jones,et al.  Idiopathic pulmonary fibrosis , 2017, The Lancet.

[9]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[10]  W. Seeger,et al.  Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. , 2017, Cell stem cell.

[11]  Young-Sik Kim,et al.  Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis , 2015, EMBO molecular medicine.

[12]  W. Altemeier,et al.  Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.

[13]  G. Drummen,et al.  The Controversial Role of Retinoic Acid in Fibrotic Diseases: Analysis of Involved Signaling Pathways , 2012, International journal of molecular sciences.

[14]  Min Goo Lee,et al.  Retinol binding protein-albumin domain III fusion protein deactivates hepatic stellate cells , 2012, Molecules and cells.

[15]  A. Lekkerkerker,et al.  Cellular players in lung fibrosis. , 2012, Current pharmaceutical design.

[16]  Jungho Kim,et al.  Recombinant fusion protein of albumin-retinol binding protein inactivates stellate cells. , 2012, Biochemical and biophysical research communications.

[17]  S. Hotchandani,et al.  Binding sites of retinol and retinoic acid with serum albumins. , 2012, European journal of medicinal chemistry.

[18]  H. Friess,et al.  StellaTUM: current consensus and discussion on pancreatic stellate cell research , 2011, Gut.

[19]  Y.-S. Kim,et al.  Formation of vitamin A lipid droplets in pancreatic stellate cells requires albumin , 2009, Gut.

[20]  P. Ping,et al.  A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A , 2007, Science.

[21]  H. Tsukamoto,et al.  Anti‐adipogenic regulation underlies hepatic stellate cell transdifferentiation , 2006, Journal of gastroenterology and hepatology.

[22]  H. Tsukamoto,et al.  Adipogenic Transcriptional Regulation of Hepatic Stellate Cells* , 2005, Journal of Biological Chemistry.

[23]  T W Evans,et al.  Review article: albumin as a drug—biological effects of albumin unrelated to oncotic pressure , 2002, Alimentary pharmacology & therapeutics.

[24]  P. Brick,et al.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.

[25]  R. Blomhoff,et al.  Storage of vitamin A in extrahepatic stellate cells in normal rats. , 1997, Journal of lipid research.

[26]  F. Takaku,et al.  Isolation and characterization of vitamin-A-storing lung cells. , 1984, Experimental cell research.

[27]  W. Seeger,et al.  Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. , 2017, Cell stem cell.

[28]  D. Brenner,et al.  Epithelial and Mesenchymal Cell Biology Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney , 2010 .

[29]  D. Warburton,et al.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? , 2008, The international journal of biochemistry & cell biology.

[30]  J. Torday,et al.  The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. , 1997, Annual review of physiology.